Le Lézard
Classified in: Science and technology, Business
Subjects: SVY, OTC

Alternet Systems Steps Up To Establish Foothold In $77 Billion Lithium Ion Battery Market


DALLAS, November 8, 2017 /PRNewswire/ --

Alternet Systems, Inc. (USOTC: ALYI) updated all past financial reports this week taking a major step forward in advancing the company's new lithium technology business strategy.  All the financial reports are available on the OTC Markets website. Management anticipates the OTC Market's status to reflect "current" imminently, once OTC Market's completes its review of the company's filings.  The filings published on OTC Market's includes detailed information on each of the lithium technologies in the company's patent portfolio.  In an online shareholder update presentation scheduled for Thursday, November 9, 2017, Randell Torno, CEO of Alternet Systems, will elaborate more on the lithium technology portfolio and the company's strategy and progress so far to establish a foothold in the $77 billion lithium ion battery market.  Mr. Torno commented, "I anticipate those taking time to view the online presentation will be surprised to find the company's plan very in tune with the prevailing market and further along than most might expect for a company that changed its strategic direction so recently."

OTC Markets Disclosure Excerpt

On July 21, 2017, the Company acquired Lithium IP Holdings in a transaction that included a management and business direction change.  Randell Torno was named the new Alternet Systems Chairman and CEO.  Edward Bollen, the President of Lithium IP Holdings, also joined the Altnernet Systems management team.  On June 23, 2017, Lithium IP Holdings executed an agreement to exclusively license ten U.S. Patented lithium battery technologies* with an option to acquire the ten U.S. Patents.  The current business plan is to develop partnerships with prominent businesses and agencies to commercialize its portfolio of lithium technologies while at the same time continuing to expand the existing portfolio. 


  
    Table 1 - Patent Portfolio List
  
    Letter I.D.    Date Issued       Patent No.
  
    A                12/25/07        7,311,993
    B                03/25/08        7,348,103
    C                 09/2/08        7,419,623
    D                12/16/08        7,465,517
    E                09/22/09        7,591,964
    F                12/03/09      Application
    G                05/18/10        7,718,154
    H                08/31/10       *7,785,740
    I                07/19/11        7,981,388
    J                06/24/14        8,758,945


*United States Government also has rights to patent

Overcharge Protection Patents 

The two patents (Patents H and J) here are of the chemical design within the cell category and specifically embody both liquid and gel electrolyte configurations.  Patent H discloses a "shuttling" mechanism via the Boron salt to essentially return overcharge electrons in a closed loop cycle and limiting the voltage rise.  Patent J discloses a chemical reaction of a polymeric material that becomes gelled or solid at a voltage just over the cell maximum voltage in a way that prohibits the flow of electrons thereby shutting the cell down.

Electrolyte Material Patents 

The first two patents (A, B) claim invention of specific Boron salts to be used in the liquid electrolyte solution of a lithium ion cell.  Patent D extends this general concept from just a liquid electrolyte solution to also include "gel" electrolyte configurations.  

Electrolyte Process Patents 

Specifically patent G provides for a process to synthesize the precursor for the Boron salts that are included in this patent portfolio.  Patent I provides for four process methods to produce a purer Boron electrolyte salt and electrolyte salt solution.  Specifically four purification processes are offered, three describe processes wherein the liquid electrolyte solution may be variously purified by passing it through sieves/columns or ion exchange columns.  The fourth purification method is to vacuum dry the solid salt at 180 C to remove impurities.

Fuel Cell Patents 

The fuel cell patents C and E in theory present a significant extension of the Boron electrolyte salt concepts to completely new market segments and multiple technologies over a range of fuel cell configurations.  Both patents list preparation methods of the Boron materials and are accompanied by a series of analytical benchtop laboratory tests indicating that they have the physical characteristics which may allow them to be utilized in a variety of fuel cell applications.  

Learn more on the company's website:

http://www.otc-alyi.com or http://www.lithiumip.com

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Alternet Systems, Inc. Contact:
Randell Torno
[email protected]
1-800-713-0297
https://www.otc-alyi.com/contact/

SOURCE Alternet Systems, Inc.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: